Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats

Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: Role of Akt ubiquitination E3 ligase TRAF6

(2014) Yingmei Zhang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Yohimbine Promotes Cardiac NE Release and Prevents LPS-Induced Cardiac Dysfunction via Blockade of Presynaptic α2A-Adrenergic Receptor

(2013) Yiyang Wang et al.   PLoS One

Protective Effect of Montelukast Which Is Cysteinyl-Leukotriene Receptor Antagonist on Gentamicin-Induced Nephrotoxicity and Oxidative Damage in Rat Kidney

(2013) Alper Otunctemur et al.   RENAL FAILURE

Glutathione Peroxidase-1 Primes Pro-Inflammatory Cytokine Production after LPS Challenge In Vivo

(2012) Steven Bozinovski et al.   PLoS One

Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats

(2011) Ghada M. Suddek   FUNDAMENTAL & CLINICAL PHARMACOLOGY

The Effects of Montelukast on Antioxidant Enzymes and Proinflammatory Cytokines on the Heart, Liver, Lungs, and Kidneys in a Rat Model of Cecal Ligation and Puncture–Induced Sepsis

(2011) Ali Kagan Coskun et al.   TheScientificWorldJOURNAL

Attenuating effect of taurine on lipopolysaccharide-induced acute lung injury in hamsters

(2009) Tapan M. Bhavsar et al.   PHARMACOLOGICAL RESEARCH

Protective Potential of Montelukast Against Hepatic Ischemia/Reperfusion Injury in Rats

(2008) Erkan Özkan et al.   JOURNAL OF SURGICAL RESEARCH

Reactive Oxygen Species Contribute to Lipopolysaccharide-Induced Teratogenesis in Mice

(2008) Lei Zhao et al.   TOXICOLOGICAL SCIENCES